Nephros (NEPH) Cash & Equivalents (2009 - 2026)
Nephros (NEPH) recorded Cash & Equivalents of $4.7 million in Q2 2026, down 7.4% from $5.07 million a year earlier but up 16.9% from the prior quarter.
Nephros (NEPH) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Nephros reported Cash & Equivalents of $5.4 million, up 43.6% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $3.76 million in FY2024 (-12.7%), $4.31 million in FY2023 (+18.5%), $3.63 million in FY2022 (-47.9%) and $6.97 million in FY2021 (-15.5%).
- Quarterly Cash & Equivalents has ranged from $2.46 million in Q3 2024 to $7.35 million in Q3 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 20.3%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 110.5% in Q3 2025, against a decline of 49.5% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.02 million (Q1 2026), $5.4 million (Q4 2025) and $5.17 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.20 Bn | 235.84 Bn | 5.13 Bn | 5.46 Bn |
| 2 | Abbott Laboratories | 185.80 Bn | 160.26 Bn | 7.39 Bn | 4.05 Bn |
| 3 | Danaher | 163.29 Bn | 142.96 Bn | 3.84 Bn | 5.68 Bn |
| 4 | Intuitive Surgical | 152.47 Bn | 132.89 Bn | 2.08 Bn | 2.98 Bn |
| 5 | Medtronic | 131.95 Bn | 97.47 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 119.59 Bn | 105.78 Bn | 4.25 Bn | 3.27 Bn |
| 7 | Boston Scientific | 64.18 Bn | 59.61 Bn | 3.43 Bn | 609.00 Mn |
| 8 | Edwards Lifesciences | 60.93 Bn | 44.24 Bn | 1.35 Bn | 3.11 Bn |
| 9 | Medline | 52.61 Bn | 49.74 Bn | 1.93 Bn | 2.32 Bn |
| 10 | Nephros | 35.98 Mn | 17.32 Mn | 3.29 Mn | 4.55 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.55 Mn |
| Jun 30, 2026 | 4.70 Mn |
| Mar 31, 2026 | 4.02 Mn |
| Dec 31, 2025 | 5.40 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.07 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Dec 31, 2024 | 3.76 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.63 Mn |
| Dec 31, 2023 | 4.31 Mn |
| Sep 30, 2023 | 4.62 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Mar 31, 2023 | 3.84 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 5.42 Mn |
| Dec 31, 2021 | 6.97 Mn |
Nephros Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NEPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NEPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NEPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();